Pedro Emanuel Cardoso Nunes

Repositório Aberto da Universidade do Porto

INSTITUTO DE CIÊNCIAS BIOMÉDICAS ABEL SALAZARPedro Emanuel Cardoso Nunes. Establishing a protocol for the detection of acute myeloid leukamia markers in liquid biopsies based on extracellular vesiclesEstablishing a protocol for the detection of acute myeloid leukaemia markers in liquid biopsies based on extracellular vesiclesPedro Emanuel Cardoso NunesEstablishing a protocol for the detection of acute myeloid leukaemia markers in liquid biopsies based on extracellular vesiclesPedro Emanuel Cardoso NunesM 2017M.ICBAS 2017MESTRADO ONCOLOGIA - ESPECIALIZAÇÃO EM ONCOLOGIA MOLECULARi    ii    iii                   iv    v                       vi  vii  viii  ix  x  xi  xii   xiii    xiv  xv   xvi  xvii  xviii  xix  xx  1  2  3    4    5  α6  7  8  9  10  11  12  13  14   15   16   17  18    19   20   21   22  23   24   et al25  et al26  27           28     29      30    31  32  33     34    35     36   37       38   39     40    41  42  43   44  45  46   47      48  49     50   51   52    53   54  55  56  57   58  Anita Boing et al.59   60   61  et al a priori62   63   64   65  66  67  68  69  70  71  Aasebo, E., R. B. Forthun, F. Berven, et al., 2016, Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients, Curr Pharm Biotechnol, 17 (1), 52-70 Akers, J. C., D. Gonda, R. Kim, et al., 2013, Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies, J Neurooncol, 113 (1), 1-11 Ao, Zheng, Richard J. Cote, and Ram H. Datar. 2016. 'Affinity-Based Enrichment of Circulating Tumor Cells.' in Richard J. Cote and Ram H. Datar (eds.), Circulating Tumor Cells (Springer New York: New York, NY). Bell, E., and M. A. Taylor, 2017, Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment, Comput Struct Biotechnol J, 15 8-13 Bellingham, S. A., M. Shambrook, and A. F. Hill, 2017, Quantitative Analysis of Exosomal miRNA via qPCR and Digital PCR, Methods Mol Biol, 1545 55-70 Boing, A. N., E. van der Pol, A. E. Grootemaat, et al., 2014, Single-step isolation of extracellular vesicles by size-exclusion chromatography, J Extracell Vesicles, 3  Boyiadzis, M., and T. L. Whiteside, 2016, Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?, Expert Rev Mol Diagn, 16 (6), 623-9 Buccisano, F., L. Maurillo, M. I. Del Principe, et al., 2012, Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia, Blood, 119 (2), 332-41 Caivano, A., F. La Rocca, V. Simeon, et al., 2016, MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report, Cell Oncol (Dordr),  Cancer Genome Atlas Research, Network, T. J. Ley, C. Miller, et al., 2013, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, N Engl J Med, 368 (22), 2059-74 Cea, M., A. Cagnetta, A. Nencioni, et al., 2013, New insights into biology of chronic myeloid leukemia: implications in therapy, Curr Cancer Drug Targets, 13 (7), 711-23 Chan, K. C., P. Jiang, Y. W. Zheng, et al., 2013, Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing, Clin Chem, 59 (1), 211-24 Chen, X., H. Xie, B. L. Wood, et al., 2015, Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia, J Clin Oncol, 33 (11), 1258-64 Colombo, M., G. Raposo, and C. Thery, 2014, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu Rev Cell Dev Biol, 30 255-89 Copelan, E. A., M. R. Grunwald, L. J. Druhan, et al., 2015, Use of molecular markers to determine postremission treatment in acute myeloid leukemia with normal cytogenetics, Hematol Oncol Stem Cell Ther, 8 (4), 143-9 De Angelis, R., P. Minicozzi, M. Sant, et al., 2015, Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study, Eur J Cancer, 51 (15), 2254-68 Desdin-Mico, G., and M. Mittelbrunn, 2017, Role of exosomes in the protection of cellular homeostasis, Cell Adh Migr, 11 (2), 127-34 Dohner, H., E. Estey, D. Grimwade, et al., 2017, Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel, Blood, 129 (4), 424-47 Dohner, H., E. H. Estey, S. Amadori, et al., 2010, Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, 115 (3), 453-74 Druker, B. J., 2008, Translation of the Philadelphia chromosome into therapy for CML, Blood, 112 (13), 4808-17 Ehninger, A., M. Kramer, C. Rollig, et al., 2014, Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia, Blood Cancer J, 4 e218 72  Erwig, L. P., and P. M. Henson, 2008, Clearance of apoptotic cells by phagocytes, Cell Death Differ, 15 (2), 243-50 Fais, S., L. O'Driscoll, F. E. Borras, et al., 2016, Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine, ACS Nano, 10 (4), 3886-99 Fang, Y., D. Garnier, T. H. Lee, et al., 2016, PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells, Angiogenesis, 19 (1), 25-38 Fayyad-Kazan, H., N. Bitar, M. Najar, et al., 2013, Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia, J Transl Med, 11 31 Gamez-Valero, A., M. Monguio-Tortajada, L. Carreras-Planella, et al., 2016, Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles' characteristics compared to precipitating agents, Sci Rep, 6 33641 Gardiner, C., M. Shaw, P. Hole, et al., 2014, Measurement of refractive index by nanoparticle tracking analysis reveals heterogeneity in extracellular vesicles, J Extracell Vesicles, 3 25361 Gold, B., M. Cankovic, L. V. Furtado, et al., 2015, Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology, J Mol Diagn, 17 (3), 209-24 He, Y., X. Jiang, and J. Chen, 2014, The role of miR-150 in normal and malignant hematopoiesis, Oncogene, 33 (30), 3887-93 Hindson, B. J., K. D. Ness, D. A. Masquelier, et al., 2011, High-throughput droplet digital PCR system for absolute quantitation of DNA copy number, Anal Chem, 83 (22), 8604-10 Holohan, C., S. Van Schaeybroeck, D. B. Longley, et al., 2013, Cancer drug resistance: an evolving paradigm, Nat Rev Cancer, 13 (10), 714-26 Hong, C. S., S. Funk, L. Muller, et al., 2016, Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer, J Extracell Vesicles, 5 29289 Hong, C. S., L. Muller, M. Boyiadzis, et al., 2014, Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia, PLoS One, 9 (8), e103310 Hong, C. S., L. Muller, T. L. Whiteside, et al., 2014, Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia, Front Immunol, 5 (160), 1-9 Horiguchi, H., M. Kobune, S. Kikuchi, et al., 2016, Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms, Haematologica, 101 (4), 437-47 Hornick, N. I., B. Doron, S. Abdelhamed, et al., 2016, AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB, Sci Signal, 9 (444), ra88 Hornick, N. I., J. Huan, B. Doron, et al., 2015, Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML, Sci Rep, 5 (11295), 1-12 Hourigan, C. S., R. P. Gale, N. J. Gormley, et al., 2017, Measurable residual disease testing in acute myeloid leukaemia, Leukemia, 31 (7), 1482-90 Hourigan, C. S., and J. E. Karp, 2013, Minimal residual disease in acute myeloid leukaemia, Nat Rev Clin Oncol, 10 (8), 460-71 Hubmann, M., T. Kohnke, E. Hoster, et al., 2014, Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse, Haematologica, 99 (8), 1317-25 Jackson, J. M., J. B. Taylor, M. A. Witek, et al., 2016, Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood, Analyst, 141 (2), 640-51 Jagannathan-Bogdan, M., and L. I. Zon, 2013, Hematopoiesis, Development, 140 (12), 2463-7 Kallergi, G., E. Politaki, S. Alkahtani, et al., 2016, Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs), Cell Physiol Biochem, 40 (3-4), 411-19 73  Kanemoto, S., R. Nitani, T. Murakami, et al., 2016, Multivesicular body formation enhancement and exosome release during endoplasmic reticulum stress, Biochem Biophys Res Commun, 480 (2), 166-72 Karas, M., K. Steinerova, D. Lysak, et al., 2016, Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission, Anticancer Res, 36 (10), 5487-98 Kayser, S., R. B. Walter, W. Stock, et al., 2015, Minimal residual disease in acute myeloid leukemia--current status and future perspectives, Curr Hematol Malig Rep, 10 (2), 132-44 Kennedy, J. A., and F. Barabe, 2008, Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia, Leukemia, 22 (11), 2029-40 Kern, W., U. Bacher, C. Haferlach, et al., 2010, The role of multiparameter flow cytometry for disease monitoring in AML, Best Pract Res Clin Haematol, 23 (3), 379-90 Khaled, S., M. Al Malki, and G. Marcucci, 2016, Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights, Oncology (Williston Park), 30 (4), 318-29 Klumperman, J., and G. Raposo, 2014, The complex ultrastructure of the endolysosomal system, Cold Spring Harb Perspect Biol, 6 (10), a016857 Kovtonyuk, L. V., K. Fritsch, X. Feng, et al., 2016, Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment, Front Immunol, 7 502 Kowal, J., G. Arras, M. Colombo, et al., 2016, Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes, Proc Natl Acad Sci U S A, 113 (8), E968-77 Kronke, J., R. F. Schlenk, K. O. Jensen, et al., 2011, Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group, J Clin Oncol, 29 (19), 2709-16 Lamba, G., S. K. Zaidi, K. Luebbers, et al., 2014, Epigenetic landscape of acute myelogenous leukemia--moving toward personalized medicine, J Cell Biochem, 115 (10), 1669-72 Lambert, J., J. Lambert, O. Nibourel, et al., 2014, MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin, Oncotarget, 5 (15), 6280-8 Li, X., F. Liu, B. Lin, et al., 2017, miR150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma, Int J Oncol,  Liang, J., Y. L. Wu, B. J. Chen, et al., 2013, The C-kit receptor-mediated signal transduction and tumor-related diseases, Int J Biol Sci, 9 (5), 435-43 Lin, M. T., L. H. Tseng, J. C. Dudley, et al., 2015, A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML, Mol Diagn Ther, 19 (6), 409-17 Linares, R., S. Tan, C. Gounou, et al., 2015, High-speed centrifugation induces aggregation of extracellular vesicles, J Extracell Vesicles, 4 29509 Livshits, M. A., E. Khomyakova, E. G. Evtushenko, et al., 2015, Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol, Sci Rep, 5 17319 Lobb, R. J., M. Becker, S. W. Wen, et al., 2015, Optimized exosome isolation protocol for cell culture supernatant and human plasma, J Extracell Vesicles, 4 27031 Logozzi, M., A. De Milito, L. Lugini, et al., 2009, High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients, PLoS One, 4 (4), e5219 Lopes-Rodrigues, V., A. Di Luca, D. Sousa, et al., 2016, Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells, Biochim Biophys Acta, 1860 (3), 618-27 Ma, M., H. Zhu, C. Zhang, et al., 2015, "Liquid biopsy"-ctDNA detection with great potential and challenges, Ann Transl Med, 3 (16), 235 Manri, C., T. Yokoi, and H. Nishida, 2017, Size-Selective Harvesting of Extracellular Vesicles for Strategic Analyses Towards Tumor Diagnoses, Appl Biochem Biotechnol, 182 (2), 609-23 74  Marcucci, G., K. S. Maharry, K. H. Metzeler, et al., 2013, Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients, J Clin Oncol, 31 (17), 2086-93 Marcucci, G., K. Mrozek, M. D. Radmacher, et al., 2011, The prognostic and functional role of microRNAs in acute myeloid leukemia, Blood, 117 (4), 1121-9 Maurillo, L., F. Buccisano, A. Piciocchi, et al., 2015, Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia, Am J Hematol, 90 (2), 125-31 Mol, E. A., M. J. Goumans, P. A. Doevendans, et al., 2017, Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation, Nanomedicine, 13 (6), 2061-65 Muller, L., C. S. Hong, D. B. Stolz, et al., 2014, Isolation of biologically-active exosomes from human plasma, J Immunol Methods, 411 55-65 Nausch, N., and A. Cerwenka, 2008, NKG2D ligands in tumor immunity, Oncogene, 27 (45), 5944-58 O'Donnell, M. R., M. S. Tallman, C. N. Abboud, et al., 2017, Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw, 15 (7), 926-57 Ofran, Y., and J. M. Rowe, 2015, Introducing minimal residual disease in acute myeloid leukemia, Curr Opin Hematol, 22 (2), 139-45 Oliveira-Rodriguez, M., S. Lopez-Cobo, H. T. Reyburn, et al., 2016, Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids, J Extracell Vesicles, 5 31803 Ommen, H. B., 2016, Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies, Ther Adv Hematol, 7 (1), 3-16 Prada-Arismendy, J., J. C. Arroyave, and S. Rothlisberger, 2016, Molecular biomarkers in acute myeloid leukemia, Blood Rev, 31 (1), 63-76 Pullarkat, V., and I. Aldoss, 2015, Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia, Crit Rev Oncol Hematol, 95 (1), 38-45 Raposo, G., and W. Stoorvogel, 2013, Extracellular vesicles: exosomes, microvesicles, and friends, J Cell Biol, 200 (4), 373-83 Sadovska, L., J. Eglitis, and A. Line, 2015, Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer, Anticancer Res, 35 (12), 6379-90 Saenz-Cuesta, M., A. Arbelaiz, A. Oregi, et al., 2015, Methods for extracellular vesicles isolation in a hospital setting, Front Immunol, 6 50 Salomon, Carlos, Miharu Kobayashi, Jorge Tapia, et al., 2015, Exosomes are fingerprints of originating cells: potential biomarkers for ovarian cancer, Research and Reports in Biochemistry, 101 Seca, H., G. M. Almeida, J. E. Guimaraes, et al., 2010, miR signatures and the role of miRs in acute myeloid leukaemia, Eur J Cancer, 46 (9), 1520-7 Shivarov, V., A. Stoimenov, B. Spassov, et al., 2014, Patient-specific microRNA expression profiles as a marker for minimal residual disease in acute myeloid leukemia, Hematology, 19 (1), 18-21 Sidney, L. E., M. J. Branch, S. E. Dunphy, et al., 2014, Concise review: evidence for CD34 as a common marker for diverse progenitors, Stem Cells, 32 (6), 1380-9 Sousa, D., R. T. Lima, and M. H. Vasconcelos, 2015, Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles, Trends Mol Med, 21 (10), 595-608 Suchorska, W. M., and M. S. Lach, 2016, The role of exosomes in tumor progression and metastasis (Review), Oncol Rep, 35 (3), 1237-44 Szczepanski, M. J., M. Szajnik, A. Welsh, et al., 2011, Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1, Haematologica, 96 (9), 1302-9 75  Taylor, D. D., and S. Shah, 2015, Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes, Methods, 87 3-10 Testa, U., E. Pelosi, and A. Frankel, 2014, CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies, Biomark Res, 2 (1), 4 Tkach, M., and C. Thery, 2016, Communication by Extracellular Vesicles: Where We Are and Where We Need to Go, Cell, 164 (6), 1226-32 Tsirigotis, P., M. Byrne, C. Schmid, et al., 2016, Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT, Bone Marrow Transplant, 51 (11), 1431-38 Tzoran, I., A. Rebibo-Sabbah, B. Brenner, et al., 2015, Disease dynamics in patients with acute myeloid leukemia: new biomarkers, Exp Hematol, 43 (11), 936-43 Valkonen, S., E. van der Pol, A. Boing, et al., 2017, Biological reference materials for extracellular vesicle studies, Eur J Pharm Sci, 98 4-16 van der Pol, E., A. N. Boing, P. Harrison, et al., 2012, Classification, functions, and clinical relevance of extracellular vesicles, Pharmacol Rev, 64 (3), 676-705 van der Pol, E., F. A. Coumans, A. Sturk, et al., 2014, Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis, Nano Lett, 14 (11), 6195-201 Walter, R. B., 2014, The role of CD33 as therapeutic target in acute myeloid leukemia, Expert Opin Ther Targets, 18 (7), 715-8 Webber, J., and A. Clayton, 2013, How pure are your vesicles?, J Extracell Vesicles, 2  Weiskopf, K., P. J. Schnorr, W. W. Pang, et al., 2016, Myeloid Cell Origins, Differentiation, and Clinical Implications, Microbiol Spectr, 4 (5),  Welton, J. L., J. P. Webber, L. A. Botos, et al., 2015, Ready-made chromatography columns for extracellular vesicle isolation from plasma, J Extracell Vesicles, 4 27269 Wojtuszkiewicz, A., G. J. Schuurhuis, F. L. Kessler, et al., 2016, Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis, Mol Cell Proteomics, 15 (4), 1281-98 Xiao, X., S. Yu, S. Li, et al., 2014, Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin, PLoS One, 9 (2), e89534 Xu, R., D. W. Greening, H. J. Zhu, et al., 2016, Extracellular vesicle isolation and characterization: toward clinical application, J Clin Invest, 126 (4), 1152-62 Yu, X., M. Odenthal, and J. W. Fries, 2016, Exosomes as miRNA Carriers: Formation-Function-Future, Int J Mol Sci, 17 (12),  Zeijlemaker, W., A. Kelder, Y. J. Oussoren-Brockhoff, et al., 2016, Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia, Leukemia, 30 (3), 708-15 Zhang, W., W. Xia, Z. Lv, et al., 2017, Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?, Cell Physiol Biochem, 41 (2), 755-68 Zhi, F., X. Cao, X. Xie, et al., 2013, Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia, PLoS One, 8 (2), e56718 76  i  ii  iii     iv      v    

Establishing a protocol for the detection of acute myeloid leukaemia markers in liquid biopsies based on extracellular vesicles

https://repositorio-aberto.up.pt/bitstream/10216/109193/2/233561.pdf

Establishing a protocol for the detection of acute myeloid leukaemia markers in liquid biopsies based on extracellular vesicles

Abstract

Similar works

Full text

Available Versions

Repositório Aberto da Universidade do Porto